KMDA
Kamada Ltd

2,173
Mkt Cap
$399.73M
Volume
80,959.00
52W High
$8.90
52W Low
$5.52
PE Ratio
19.51
KMDA Fundamentals
Price
$6.68
Prev Close
$6.93
Open
$7.00
50D MA
$6.88
Beta
0.72
Avg. Volume
72,788.30
EPS (Annual)
$0.2516
P/B
1.51
Rev/Employee
$383,221.43
Loading...
Loading...
News
all
press releases
Kamada (NASDAQ:KMDA) Rating Lowered to Buy at Wall Street Zen
Wall Street Zen lowered shares of Kamada from a "strong-buy" rating to a "buy" rating in a report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
FY2025 Earnings Estimate for Kamada Issued By HC Wainwright
Kamada Ltd. (NASDAQ:KMDA - Free Report) - Analysts at HC Wainwright reduced their FY2025 earnings per share estimates for shares of Kamada in a research report issued to clients and investors on...
MarketBeat·6d ago
News Placeholder
What is Sidoti Csr's Forecast for Kamada FY2025 Earnings?
Kamada Ltd. (NASDAQ:KMDA - Free Report) - Equities research analysts at Sidoti Csr boosted their FY2025 earnings estimates for shares of Kamada in a report issued on Monday, November 10th. Sidoti Csr...
MarketBeat·7d ago
News Placeholder
Kamada (KMDA) is an Incredible Growth Stock: 3 Reasons Why
Kamada (KMDA) possesses solid growth attributes, which could help it handily outperform the market.
Zacks·9d ago
News Placeholder
Kamada (NASDAQ:KMDA) Posts Quarterly Earnings Results
Kamada (NASDAQ:KMDA - Get Free Report) posted its quarterly earnings data on Monday. The biotechnology company reported $0.09 EPS for the quarter, missing analysts' consensus estimates of $0.10 by...
MarketBeat·9d ago
News Placeholder
Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Kamada (KMDA) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks·10d ago
News Placeholder
Kamada (KMDA) Misses Q3 Earnings Estimates
Kamada (KMDA) delivered earnings and revenue surprises of -10.00% and +1.64%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·10d ago
News Placeholder
An Overview of Kamada's Earnings
read more...
Benzinga·13d ago
News Placeholder
Countdown to Kamada (KMDA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top-and-bottom-line estimates for Kamada (KMDA), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2025.
Zacks·14d ago
News Placeholder
Regenxbio (RGNX) Reports Q3 Loss, Beats Revenue Estimates
Regenxbio (RGNX) delivered earnings and revenue surprises of +13.04% and +23.73%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago

Latest KMDA News

View

Advertisement|Remove ads.

Advertisement|Remove ads.